If lower levels of α-synuclein pathology mirror Lewy pathology in the brain (as seen in synucleinopathy patients), then higher plasma apoE4 levels would indeed be associated with more α-synuclein pathology in the MCI-ADD subjects in the current cohort. The gene discussed is APOE; the disease is synucleinopathy.